MOUNTAIN VIEW, Calif., Oct. 23, 2012 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced the renewal of its contract with the top-ranked non-profit, integrated health system Partners HealthCare. Following more than a decade of success using Omnicell solutions throughout its hospitals, Partners HealthCare chose to extend its relationship with Omnicell with an exclusive agreement for pharmacy automation.
(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)
Partners HealthCare was founded by two of the nation's leading academic medical centers, Brigham and Women's Hospital and Massachusetts General Hospital. Those hospitals consistently rank among the top ten hospitals nationwide in the U.S. News & World Report Best Hospitals. Massachusetts General Hospital was ranked first and Brigham and Women's Hospital was ranked ninth in the report's 2012-2013 national Honor Roll.
Partners HealthCare's decision to continue its relationship with Omnicell is the most recent example of the health system's ongoing efforts to provide the most innovative clinician-centered technology.
"We have built our reputation as a world-class institution by giving the best care to our patients. Ensuring that we have the leading technology on the market is vital to the safety of our patients and our hospitals' continued success," said William Churchill, M.S., R.Ph., executive director of pharmacy services, Brigham and Women's Hospital.
This exclusive agreement reflects Partners HealthCare's commitment to providing the highest quality of care while ensuring both patient and clinician satisfaction. To date, Omnicell's medication automation solutions are implemented throughout the hospitals within the Partners HealthCare system, including pharmacy, nursing and anesthesia workstations in operating rooms, with plans for increased deployment over the course of this contract.
"Technology-based solutions have helped tremendously in managing workflow and standardizing operations within Partners HealthCare," said Meg Clapp, chief pharmacy officer, Massachusetts General Hospital. "Advances like automated dispensing cabinets, medication carts, pharmacy carousels and medication packaging software allow our clinicians to more readily access the medication, supplies and information they need to provide our patients with the exceptional care they have come to expect from our facilities."
"Omnicell shares in Partners HealthCare's commitment to the highest standards of patient safety, clinician satisfaction and overall care quality," said J. Christopher Drew, executive vice president, field operations at Omnicell. "We are pleased to continue our relationship with Partners HealthCare to provide Omnicell's leading medication automation solutions throughout its hospitals to help fulfill its goal of offering patient-specific solutions. We look forward to working with Partners HealthCare as it succeeds in its mission to provide outstanding care to the greater
Boston community."
About Partners HealthCare
Partners HealthCare is an integrated health system founded by Brigham and Women's Hospital and Massachusetts General Hospital. In addition to its two academic medical centers, the Partners system includes community and specialty hospitals, a managed care organization, community health centers, a physician network, home health and long-term care services, and other health-related entities. Partners is one of the nation's leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. Partners HealthCare is a non-profit organization.
About Omnicell
Omnicell,
Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.
Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.
MTS Medication Technologies, a wholly-owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.
For more information about Omnicell, please visit www.omnicell.com. Visit www.mts-mt.com for more information about MTS.
OMCL - G
SOURCE Omnicell, Inc.
Back to Press Release
Download PDF
